HSV-1 in brain and risk of Alzheimer's disease
HSV-1 in brain and risk of Alzheimer's disease
复制标题
DOI:
10.1016/s0140-6736(05)79057-7
复制
发表时间:
1998-05-02
期刊:
影响因子:
168.9
通讯作者:
Poirier, J
中科院分区:
文献类型:
--
作者:
Beffert, U;Bertrand, P;Poirier, J
Brains from 73 elderly individuals with neuropathologically-confirmed Alzheimer's disease (34 men, age range 53-93 years) and 33 without Alzheimer's disease (27 men, age range 43-95 years) were investigated [date and place not given]. DNA was extracted from brain tissue and used as a template to amplify, by polymerase chain reaction, a 138 bp fragment from the glycoprotein D gene of herpes simplex virus 1 (HSV-1). Apolipoprotein E (apoE) genotype was determined with allele-specific primers. There was no significant difference in the observed apoE ε4 allele frequency between HSV-1-positive Alzheimer's disease patients and HSV-1-negative patients (37 vs. 24%,P=0.19 by χ2). HSV-1-positive ratio did not differ significantly between Alzheimer's disease patients and controls (74 vs. 73%;P=0.89). No increased susceptibility to HSV-1 infection was found among apoE ε4 allele carriers compared with non-ε4 carriers irrespective of pathology (81 vs. 68%;P=0.20). It is concluded that HSV-1 does not confer increased risk for Alzheimer's disease when combined with the presence of an ε4 allele of apoE, that HSV-1 alone is not an independent risk factor for Alzheimer's disease and that apoE ε4 allele carriers are not more susceptible to HSV-1 infection than non-carriers.